Dec 11, 2024
Dec 11, 2024
chat
FDA VRBPAC Meeting | RSV Vaccine Safety in Pediatric Populations, Program Overviews + More | Dec. 12
Agenda
Topic I
- Open Session: Considerations for Respiratory Syncytial Virus (RSV) Vaccine Safety in Pediatric Populations
Topic II
- Open Session: Program Overviews
- Laboratory of Immunoregulation (LI)
- Laboratory of Retroviruses (LR) research programs in the Division of Viral Products (DVP)
- Office of Vaccines Research and Review (OVRR)
- Center for Biologics Evaluation and Research (CBER)
CHD.TV offers a wide range of content pertaining to children's health. We regularly stream hearings, meetings and lectures from the World Economic Forum, National Institutes of Health, World Health Organization and other entities to keep you up to date the tactics and ideologies of those who influence public health, though Children's Health Defense may not have any affiliation with these organizations or individuals.
*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.